Cotización Dominari - DOMH

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

1.74

Postura de Compra

1.70

Postura de Venta

1.80

Volume Operado de la Acción

1.74 Rango del Día 1.74

1.70 Rango de 52 semanas 3.2073

Capitalización de Mercado [m]

10.327M

Precio Anterior

1.756

Precio de Apertura

1.74

Hora

1.76

Última hora de negociación

09:29:32

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

8,780

Acciones en circulación

5,934,917

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.42

Beneficio por acción (BPA)

-3.86

turnover

2.04M

Beneficio neto

-22.88M

Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including t... Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Mostrar más

Sector

Security Brokers & Dealers

Industria

Security Brokers & Dealers

Sitio web

www.dominariholdings.com

Sede

Wilmington, Delaware, USA

Fundado

1970

Dominari Holdings Inc is listed in the Security Brokers & Dealers sector of the NASDAQ with ticker DOMH. The last closing price for Dominari was US$1.76. Over the last year, Dominari shares have traded in a share price range of US$ 1.70 to US$ 3.2073.

Dominari currently has 5,934,917 shares in issue. The market capitalisation of Dominari is US$10.42 million. Dominari has a price to earnings ratio (PE ratio) of -0.42.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.09	-4.91803278689	1.83	1.85	1.7	8529	1.77627511	CS
4	-0.23	-11.6751269036	1.97	2.07	1.7	10238	1.85757964	CS
12	-0.5	-22.3214285714	2.24	2.49	1.7	8780	1.99745559	CS
26	-0.5	-22.3214285714	2.24	3.2	1.7	10473	2.3128554	CS
52	-1.29	-42.5742574257	3.03	3.2073	1.7	10967	2.33361027	CS
156	-1.47	-45.7943925234	3.21	4.45	1.7	14932	2.92927437	CS
260	-1.47	-45.7943925234	3.21	4.45	1.7	14932	2.92927437	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ATPCAgape ATP Corporation	US$ 0.2203 (90.41%)	30.36M
RDHLRedhill Biopharma Ltd	US$ 0.5485 (42.80%)	165.1M
BBLGBone Biologics Corporation	US$ 3.055 (41.44%)	56.64M
BMEABiomea Fusion Inc	US$ 7.50 (34.65%)	4.33M
IMRXImmuneering Corporation	US$ 1.4601 (29.21%)	55.09M
VWEVintage Wine Estates Inc	US$ 0.0313 (-39.69%)	17.34M
ALXOALX Oncology Holdings Inc	US$ 3.225 (-32.81%)	4.12M
LABStandard BioTools Inc	US$ 1.535 (-31.47%)	2.6M
ATECAlphatec Holdings Inc	US$ 7.43 (-26.44%)	4.94M
NCNCnoco noco Inc	US$ 0.2194 (-23.55%)	5.79M
RDHLRedhill Biopharma Ltd	US$ 0.5485 (42.80%)	165.1M
NVDANVIDIA Corporation	US$ 116.25 (-0.66%)	117.93M
SQQQProShares UltraPro Short QQQ	US$ 8.6406 (0.59%)	68.71M
HUGEFSD Pharma Inc	US$ 0.1069 (5.84%)	68.03M
BBLGBone Biologics Corporation	US$ 3.055 (41.44%)	56.64M